Clinical Trials Directory

Trials / Unknown

UnknownNCT04929054

PCR Based CEUS in BI RADS 4A Nodules

Principal Component Regression Based Contrast Enhanced Ultrasound Evaluating System in the Management of BI-RADS 4A Breast Nodules

Status
Unknown
Phase
Study type
Observational
Enrollment
260 (estimated)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study was to investigate the added value of Principal Component Regression (PCR) based contrast-enhanced ultrasound (CEUS) for differentiating low risk patients with breast nodules categorized as 4A using the Breast Imaging Reporting and Data System (BI-RADS).

Detailed description

The aim of this study was to investigate the added value of Principal Component Regression (PCR) based contrast-enhanced ultrasound (CEUS) for differentiating low risk patients with breast nodules categorized as 4A using the Breast Imaging Reporting and Data System (BI-RADS). The study included patients with 4A nodules confirmed by core biopsy and/or surgery. The CEUS parameters were assessed and PCR scores were calculated to evaluated the added value in BI-RADS 4A nodules.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTimagingultrasound and contrast enhanced ultrasound for BI RADS4A breast modules

Timeline

Start date
2019-04-01
Primary completion
2020-05-30
Completion
2021-12-30
First posted
2021-06-18
Last updated
2021-07-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04929054. Inclusion in this directory is not an endorsement.